BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Autolus

Autolus logo

Founded
2014
Patents
92
Clinical Trials
6
Publications
29

Technologies

Gene Therapy Startups

Autolus utilises advanced cell programming CAR-T and manufacturing technologies and we have established a development-stage pipeline of products for the treatment of haematological malignancies and solid tumours.


Posts Mentioning This Company

The Promise Of Cell Technologies In Immunotherapy

  
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some cancers. Cell technologies, as a growing sub-field in the immunotherapy landscape, have progressed considerably and now represent a $26 billion financial opportunity by 2030, according to a report by Roots …
SHARE